Citation: | CHENG Zhaoyu, LIU Xuan, XIAN Yidan, WEI Siyue, LIU Yuanyuan, LIU Fengli, YANG Jie, YU Maohe, LI Changping, CUI Zhuang. Analysis of potential categories of sexual behaviors among male students who have sex with men and the status of pre-exposure prophylaxis use[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2024, 45(7): 974-977. doi: 10.16835/j.cnki.1000-9817.2024215 |
[1] |
GBD 2017 HIV Collaborators. Global, regional, and national incidenc-e, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017[J]. Lancet HIV, 2019, 6(12): e831-e859. doi: 10.1016/S2352-3018(19)30196-1
|
[2] |
ROJAS P, MALOW R, RUFFIN B, et al. The HIV/AIDS epidemic in the dominican republic: key contributing factors[J]. J Int Assoc Phys AIDS Care (Chic), 2011, 10(5): 306-315. doi: 10.1177/1545109710397770
|
[3] |
HE N. Research progress in the epidemiology of HIV/AIDS in China[J]. China CDC Weekly, 2021, 3(48): 1022-1030. doi: 10.46234/ccdcw2021.249
|
[4] |
LAI J, PAN P, LIN Y, et al. A survey on HIV/AIDS-related knowledge, attitudes, risk behaviors, and characterivstics of men who have sex with men among university students in Guangxi, China[J]. Biomed Res Int, 2020, 2020: 7857231.
|
[5] |
YANG Z, HUANG Z, DONG Z, et al. Prevalence of high-risky behaviors in transmission of HIV among high school and college student MSM in China: a Meta-analysis[J]. BMC Public Health, 2015, 15: 1272. doi: 10.1186/s12889-015-2614-4
|
[6] |
ANDERSON P L, GLIDDEN D V, LIU A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men[J]. Sci Transl Med, 2012, 4(151): 151ra125.
|
[7] |
SCHAEFER R, SCHMIDT H A, RAVASI G, et al. Adoption of guidelines on and use of oral pre-exposure prophylaxis: a global summary and forecasting study[J]. Lancet HIV, 2021, 8(8): e502-e510. doi: 10.1016/S2352-3018(21)00127-2
|
[8] |
MOLINA J M, CAPITANT C, SPIRE B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection[J]. N Engl J Med, 2015, 373(23): 2237-2246. doi: 10.1056/NEJMoa1506273
|
[9] |
LANZA S T, RHOADES B L. Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment[J]. Prev Sci, 2013, 14(2): 157-168. doi: 10.1007/s11121-011-0201-1
|
[10] |
WU Z, CHEN J, SCOTT S R, et al. History of the HIV epidemic in China[J]. Curr HIV/AIDS Rep, 2019, 16(6): 458-466. doi: 10.1007/s11904-019-00471-4
|
[11] |
张北川, 刘明华, 于增照. 对男男性行为者艾滋病防治医学领域文献中某些内容和专用词的辨析[J]. 中国艾滋病性病, 2021, 27(9): 1021-1025. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA202109030.htm
ZHANG B C, LIU M H, YU Z Z. Identification of certain elements and terminology in the medical field of HIV prevention and treatment among men who have sex with men[J]. Chin J AIDS STD, 2021, 27(9): 1021-1025. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA202109030.htm
|
[12] |
郭佳欢, 康文婷, 刘童童, 等. 不同男男性行为者对PrEP使用意愿及影响因素分析[J]. 中国艾滋病性病, 2022, 28(12): 1375-1380. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA202212008.htm
GUO J H, KANG W T, LIU T T, et al. Willingness of pre-exposure prophylaxis and influencing factors among different subgroups of men who have sex with men[J]. Chin J AIDS STD, 2022, 28(12): 1375-1380. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA202212008.htm
|
[13] |
曾宪华, 肖琳, 张岩波. 潜在类别分析原理及实例分析[J]. 中国卫生统计, 2013, 30(6): 815-817. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201306010.htm
ZENG X L, XIAO L, ZHANG Y B. Principle of latent class analysis and case analysis[J]. Chin J Health Stat, 2013, 30(6): 815-817. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWT201306010.htm
|
[14] |
BARAKAT H, BARAKAT H, BAAJ M K. CVD and obesity in transitional syria: a perspective from the middle east[J]. Vasc Health Risk Manag, 2012, 8: 145-150.
|
[15] |
FISHER D G, REYNOLDS G L, NAPPER L E. Use of crystal methamphetamine, viagra, and sexual behavior[J]. Curr Opin Infect Dis, 2010, 23(1): 53-56. doi: 10.1097/QCO.0b013e328334de0b
|
[16] |
何佳晋, 袁璐, 吴超. 2010—2019年中国艾滋病流行时空分布特征[J]. 中华疾病控制杂志, 2022, 26(5): 541-546. https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202205009.htm
HE J J, YUAN L, WU C. Temporal-spatial distribution of AIDS epidemic in China, 2010-2019[J]. Chin J Dis Control Prev, 2022, 26(5): 541-546. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-JBKZ202205009.htm
|
[17] |
WANG H, ZHANG Y, MEI Z, et al. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP)[J]. BMC Infect Dis, 2019, 19(1): 721. doi: 10.1186/s12879-019-4355-y
|
[18] |
CHEN H, YANG Y, HUANG Y, et al. Prevalence of poppers use and its sexual risks among men who have sex with men in southwestern China: a cross-sectional study[J]. BMC Public Health, 2018, 18(1): 1103. doi: 10.1186/s12889-018-6010-8
|
[19] |
TIEU H V, LI X, DONNELL D, et al. Anal sex role segregation and versatility among men who have sex with men: explore study[J]. J Acquir Immun Defic Syndr, 2013, 64(1): 121-125. doi: 10.1097/QAI.0b013e318299cede
|
[20] |
OKAFOR C N, GORBACH P M, RAGSDALE A, et al. Correlates of preexposure prophylaxis (PrEP) use among men who have sex with men (MSM) in Los Angeles, California[J]. J Urban Health, 2017, 94(5): 710-715. doi: 10.1007/s11524-017-0172-z
|
[21] |
SOUSA A F L, LIMA S, RIBEIRO C J N, et al. Adherence to pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Portuguese-Speaking Countries[J]. Int J Environ Res Public Health, 2023, 20(6): 4881. doi: 10.3390/ijerph20064881
|
[22] |
NEWCOMB M E, MORAN K, FEINSTEIN B A, et al. Pre-exposure prophylaxis (PrEP) use and condomless anal sex: evidence of risk compensation in a cohort of young men who have sex with men[J]. J Acquir Immun Defic Syndr, 2018, 77(4): 358-364. doi: 10.1097/QAI.0000000000001604
|
[23] |
CHAN P A, GLYNN T R, OLDENBURG C E, et al. Implementation of preexposure prophylaxis for human immunodeficiency virus prevention among men who have sex with men at a new england sexually transmitted diseases clinic[J]. Sex Transm Dis, 2016, 43(11): 717-723.
|